Rise in Unwanted Pregnancies to Spur Contraceptives Market, Poised to Register Downturn due to COVID-19 Pandemic
Demand for contraceptives to register a robust 6.4% CAGR during the forecast period (2020-2025). The global contraceptives market shall surpass a valuation of US$ 37,242.7 Mn by the end of 2025.
Most unwanted pregnancies occur among adolescents and young women. Such pregnancies are a major source of the prevalence of sexually transmitted diseases (STDs) such as HIV, chlamydia, genital herpes and hepatitis B.
With this ever-increasing risk, there is a rise in awareness about modern contraceptives. Governments across the world have heavily invested in family planning and sex education programs to spread awareness about the dangers of STDs.
Other trends, notably the introduction of new, innovative and low cost contraceptive devices by key market players is also expected to significantly leverage the contraceptives market. For instance, Agile Therapeutics is performing a stage 3 trial for Twirla, a contraceptive patch designed to deliver a low daily dose of estrogen.
The COVID-19 pandemic is poised to bring about a downturn in the sales of contraceptives, owing to social distancing and limited physical contact among young people. The global supply of external physical barriers such as condoms shall experience a drop, owing to tighter border restrictions regarding import and export of products and reduced production.
Contraceptive Devices to Acquire Maximum Market Share
The contraceptive devices segment shall contribute to the maximum growth of the contraceptives market. Contraceptive devices are projected to capture more than half of the global contraceptives market during the forecast period. This is attributed to the major side effects of ingesting contraceptive drugs, particularly among women.
These include nausea, headache, weight gain, increased bleeding, dysmenorrhea and menstrual changes. Moreover, the introduction of custom-fit condoms by key market players is expected to burgeon the segment’s market share. Projected CAGR for the contraceptive devices segment is pegged at 6.6% during the forecast period.
Know More Details About the Report
North America to Remain Kingpin, Asia-Pacific Expanding Healthily
North America is anticipated to dominate the contraceptives market, in the wake of growing prevalence of unintended pregnancies, rising demand for reversible contraceptives and public sector initiatives to provide funding for family planning and contraception. The region is expected to surpass a valuation of US$ 12,987.4 by 2025. Projected CAGR for the same is pegged at 6.6% during the forecast period.
Asia-Pacific is emerging as a burgeoning market for contraceptives. High incidence of the spread of STDs due to a rapidly expanding population is a key motivator for the expansion of the contraceptives market.
Realizing this, governments across the region have initiated awareness campaigns on contraceptives in rural and urban areas. The contraceptives market in the Asia-Pacific is projected to surpass a value of US$ 7,925.7 by the end of 2025, expanding at a CAGR of 6.8%.
Product Research & Development Key Growth Levers of Companies
The global contraceptives market is highly fragmented. Major market players such as Allergen, plc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd., Bayer AG and Janssen Pharmaceutical Company account for half of the total market share. The companies primarily concentrate on product launches in order to broaden their market footprint.
Pfizer Inc’s Sayana Press, for instance, is the first injectable contraceptive for women available in the U.K. The company is also in the process of conducting a study evaluating levonorgestrel and ethinyl estradiol as potential oral contraceptives.
Merck & Co, Inc., offers contraceptive care in the form of combined oral pills, vaginal rings, intrauterine devices and sub-dermal implants. Popular products include Cyclessa, Desogen, NuvaRing, Implanon and Nexplanon.
Another important player, Cipla, manufactures oral contraceptives named Crisanta. The medicine contains Drospirenone which prevents the fertilization of the egg with the sperm. It also induces hormonal changes contributing to the prevention of pregnancy.
Avail customized purchase options for your needs
COVID-19 Market Insights:
The outbreak of the novel coronavirus respiratory disease, or COVID-19, has affected millions globally. As the risk of infections grows exponentially, countries are taking heavy precautionary measures to contain the spread of the deadly virus.
With people practicing social distancing, physical contact of any kind, be it handshakes, hugs, kisses or sexual intercourse has been significantly restricted. This is anticipated to significantly impact the sales of contraceptive devices during the forecast period.
Physical barriers, especially condoms, are anticipated to witness a downturn, owing to shutting down of several production units. In Asia, several Chinese factories were shuttered when the pandemic initially broke out and workers were forced to stay home in order to contain the spread of the infection. Since most condom manufacturers are situated in Asia, the global supply of the physical contraceptive barrier shall be disrupted.
The closing of international borders in the wake of the pandemic has limited delivery flows of contraceptives, essential maternal health medicines and antiretroviral drugs. Fortunately, the healthcare industry has recognized this and key players are bolstering efforts to stave off the negative impact of supply-chain disruptions in the global contraceptives market.
The UN Population Fund (UNFPA), in its interim technical brief in March 2020, advocated governments to promote public and private partnership to mobilize the private sector to enhance supplies of sanitary items and medical equipment and redouble efforts to ensure the procurement, provision, appropriate administration and in-country distribution of required sexual and reproductive health products (SRH), continue investing in reproductive and sexual health supply chain and protective clothing for clinical management of COVID-19.
Global Contraceptives Market Segmentation
Fact.MR has studied the global contraceptives market with detailed segmentation on the basis of product type, distribution channel and key regions.
- Contraceptive drugs (hormonal):
- Oral Contraceptives:
- Combined Contraceptives
- Mini pills
- Contraceptive Injectable
- Topical Contraceptive Patch
- Contraceptive Devices:
- Male Contraceptive Devices
- Female Contraceptive Devices:
- Female Condoms
- Contraceptive Diaphragms
- Contraceptive Sponges
- Contraceptive Vaginal Rings
- Intrauterine Devices
- Sub-dermal Contraceptive Implants
- Non-surgical Permanent Contraception Devices
- Hospital Pharmacy:
- Independent Pharmacy
- Online Platform
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than the addressee(s) is unauthorized and prohibited.”
Global Contraceptives Market- Scope of the Report
The recent study by Fact.MR on global contraceptives market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that are currently determining the growth of the global contraceptives market. This report explicates on vital dynamics such as the drivers, restraints and opportunities for key market players along with key stakeholders as well as emerging players associated with the manufacturing of contraceptive devices. The study also provides dynamics that are responsible for influencing the future status of the global contraceptives market over the forecast period.
A detailed assessment of global contraceptives market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the global contraceptives market along with their product portfolio enhances the reliability of this comprehensive research study.
Global Contraceptives Market: Report Summary
The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in global contraceptives market across the globe.
A comprehensive estimate on global contraceptive market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of global contraceptives market during the forecast period. Price point comparison by region with global average price is also considered in the study.
Global Contraceptives Market: Analysis on Market Size Evaluation
Global contraceptives market has been analyzed for each market segment, in terms of value (US$ Mn).
Market estimates at global and regional levels for contraceptives is available in terms of “US$ Mn” for value, along with market attractiveness evaluation in the report. A Y-o-Y growth contrast on prominent contraceptive devices segments, along with market attractiveness evaluation has been incorporated in the report.
Global Contraceptives Market: Inspected Assessment on Regional Segments
Key sections have been elaborated in the global contraceptives report, which have helped to deliver projection on the regional markets. These chapters include the regional macros (economic and business environment outlook), which are expected to have a momentous influence on the growth of global contraceptives market during the forecast period.
Country-specific valuation on demand for assistive devices has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. Detailed breakup in terms of value for emerging countries has also been included in the report.
Global Contraceptives Market: In-depth Analysis on Competitive Landscape
The report sheds light on the leading manufacturers of contraceptives along with their detailed profiles. Essential and up-to-date data information related to the market performers, who are principally engaged in the production of contraceptives, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
The Rise of Intelligent Packaging
Personalized, Connected and Sustainable
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.